Cancer Cause and Prevention Research in California
Cancer Cause and Prevention Research (93.393) awarded $465 million to recipients in California in 273 grants from fiscal 2021 to 2025, 13% of the program's national total. Kaiser Foundation Hospitals received the most, $66.2 million.
- Awarded in California$465 million
- Awards273
- Share of the program13%
- Rank among states1st of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 148 | $90.3 million |
| FY 2022 | 157 | $95.2 million |
| FY 2023 | 161 | $93.7 million |
| FY 2024 | 148 | $92.6 million |
| FY 2025 | 138 | $93.5 million |
Recipients in California
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Kaiser Foundation Hospitals | Nonprofits | 28 | $66.2 million |
| The Regents of the University of California, San Francisco | Colleges and universities | 36 | $64.1 million |
| University of Southern California | Colleges and universities | 30 | $53.2 million |
| The Leland Stanford Junior University | Colleges and universities | 23 | $39.7 million |
| Beckman Research Institute of the City of Hope | Nonprofits | 22 | $33.6 million |
| University of California, San Diego | Colleges and universities | 24 | $32.0 million |
| University of California, Davis | Colleges and universities | 12 | $28.0 million |
| University of California Irvine | Colleges and universities | 18 | $24.8 million |
| University of California, Los Angeles | Colleges and universities | 20 | $22.3 million |
| Cedars-Sinai Medical Center | Nonprofits | 12 | $19.5 million |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to California?
$465 million from fiscal 2021 to 2025, across 273 awards. California ranks 1st of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in California?
The largest recipient is Kaiser Foundation Hospitals, with $66.2 million in 28 awards. Next are The Regents of the University of California, San Francisco and University of Southern California.
Can organizations in California apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in California
- Grants to States for Medicaid
- Education Stabilization Fund
- Highway Planning and Construction
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Federal Transit Formula Grants
- Title I Grants to Local Educational Agencies
- Head Start